Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical TrialsChenyu Lin, Mitchell E. Horwitz, Claudio G. Brunstein et al.|Transplantation and Cellular Therapy|2023Cited by 16
Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplant with Omidubicel Demonstrates Sustained Clinical Improvement Versus Standard Myeloablative Umbilical Cord Blood Transplantation (UCBT): Final Results of a Phase III Randomized, Multicenter StudyMitchell E. Horwitz, Guillermo Sanz, Patrick J. Stiff et al.|Transplantation and Cellular Therapy|2022Cited by 1
CT-314 Multicenter Long-Term Follow Up of Allogeneic Hematopoietic Stem Cell Transplantation With Omidubicel: A Pooled Analysis of Five Prospective Clinical TrialsChenyu Lin, Mitchell E. Horwitz, Aurélie Schwarzbach et al.|Clinical Lymphoma Myeloma & Leukemia|2022Cited by 1